Myocarditis, pericarditis, and COVID-19 mRNA-vaccination.
作者信息
Sookaromdee Pathum, Wiwanitkit Viroj
机构信息
Private Academic Consultant, Bangkok, Thailand.
Honorary professor, Dr DY Patil University, Pune, India.
出版信息
Glob Cardiol Sci Pract. 2022 Jun 30;2022(1-2):e202207. doi: 10.21542/gcsp.2022.7.
Abstract
摘要
相似文献
1
Myocarditis, pericarditis, and COVID-19 mRNA-vaccination.心肌炎、心包炎与新冠病毒mRNA疫苗接种
Glob Cardiol Sci Pract. 2022 Jun 30;2022(1-2):e202207. doi: 10.21542/gcsp.2022.7.
2
Booster dose of COVID-19 mRNA vaccine does not increase risks of myocarditis and pericarditis compared with primary vaccination: New insights from the vaccine adverse event reporting system.与基础免疫相比，COVID-19 mRNA 疫苗加强针不会增加心肌炎和心包炎的风险：疫苗不良事件报告系统的新见解。
Front Immunol. 2022 Sep 12;13:938322. doi: 10.3389/fimmu.2022.938322. eCollection 2022.
3
Pericarditis and myocarditis after COVID-19 mRNA vaccination in a nationwide setting.在全国范围内，COVID-19 mRNA 疫苗接种后出现的心包炎和心肌炎。
Ann Acad Med Singap. 2022 Feb;51(2):96-100. doi: 10.47102/annals-acadmedsg.2021425.
4
5
Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study.意大利 12 至 39 岁人群接种 COVID-19 mRNA 疫苗后的心肌炎和心包炎上市后主动监测：多数据库、自身对照病例系列研究。
PLoS Med. 2022 Jul 28;19(7):e1004056. doi: 10.1371/journal.pmed.1004056. eCollection 2022 Jul.
6
Myocarditis and Pericarditis following COVID-19 Vaccination: Inequalities in Age and Vaccine Types.新冠病毒疫苗接种后的心肌炎和心包炎：年龄及疫苗类型方面的不平等现象
J Pers Med. 2021 Oct 28;11(11):1106. doi: 10.3390/jpm11111106.
7
Reports of myocarditis and pericarditis following mRNA COVID-19 vaccination: a systematic review of spontaneously reported data from the UK, Europe and the USA and of the scientific literature.报告显示，接种 mRNA COVID-19 疫苗后可能引发心肌炎和心包炎：对来自英国、欧洲和美国的自发报告数据以及科学文献的系统评价。
BMJ Open. 2022 May 25;12(5):e059223. doi: 10.1136/bmjopen-2021-059223.
8
Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination - PCORnet, United States, January 2021-January 2022.SARS-CoV-2 感染和 mRNA COVID-19 疫苗接种后的心脏并发症 - PCORnet，美国，2021 年 1 月至 2022 年 1 月。
MMWR Morb Mortal Wkly Rep. 2022 Apr 8;71(14):517-523. doi: 10.15585/mmwr.mm7114e1.
9
Risk of myopericarditis following COVID-19 mRNA vaccination in a large integrated health system: A comparison of completeness and timeliness of two methods.在大型综合医疗体系中，COVID-19 mRNA 疫苗接种后的心肌炎风险：两种方法的完整性和及时性比较。
Pharmacoepidemiol Drug Saf. 2022 Aug;31(8):921-925. doi: 10.1002/pds.5439. Epub 2022 Apr 16.
10
Myocarditis and pericarditis following mRNA COVID-19 vaccination in younger patients: is there a shared thread?mRNA COVID-19 疫苗接种后年轻患者的心肌炎和心包炎：是否存在共同线索？
Expert Rev Cardiovasc Ther. 2022 Feb;20(2):87-90. doi: 10.1080/14779072.2022.2044305. Epub 2022 Feb 25.
本文引用的文献
1
Myocarditis and pericarditis in association with COVID-19 mRNA-vaccination: cases from a regional pharmacovigilance centre.与新冠病毒mRNA疫苗接种相关的心肌炎和心包炎：来自地区药物警戒中心的病例
Glob Cardiol Sci Pract. 2021 Oct 30;2021(3):e202118. doi: 10.21542/gcsp.2021.18.
2
Acute myocarditis after coronavirus disease 2019 vaccination.2019冠状病毒病疫苗接种后发生的急性心肌炎。
Anatol J Cardiol. 2021 Nov;25(11):841-842. doi: 10.5152/AnatolJCardiol.2021.689.
3
Dengue After COVID-19 Vaccination: Possible and Might be Missed.新冠疫苗接种后的登革热：有可能发生且可能被漏诊。
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211047229. doi: 10.1177/10760296211047229.
4
Electrocardiographic Changes in Dengue Fever: A Review of Literature.登革热的心电图变化：文献综述
Int J Gen Med. 2021 Sep 14;14:5607-5614. doi: 10.2147/IJGM.S328755. eCollection 2021.
5
Expected Viscosity After COVID-19 Vaccination, Hyperviscosity and Previous COVID-19.新冠疫苗接种后的预期粘度、高粘度与既往新冠病毒感染
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211020833. doi: 10.1177/10760296211020833.
Zotero 插件